AIMI — AIM ImmunoTech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for AIM ImmunoTech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	39	48.3	34.2	13.1	3.98
Net Total Accounts Receivable
Net Total Receivables	1.12	1.64	1.68	1.18	—
Prepaid Expenses
Total Current Assets	40.3	50.2	36.3	14.6	4.18
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.65	4.2	1.02	0.824	0.726
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	64.6	57.7	40.5	19.4	8.61
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	1.1	0.673	1.36	8.65	9.54
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.29	0.82	2.02	9.15	9.93
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	61.3	56.9	38.5	10.2	-1.32
Total Liabilities & Shareholders' Equity	64.6	57.7	40.5	19.4	8.61
Total Common Shares Outstanding
Total Preferred Shares Outstanding